# Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms

> **NCT00934427** · PHASE3 · UNKNOWN · sponsor: **MediQuest Therapeutics** · enrollment: 100 (estimated)

## Conditions studied

- Raynaud Disease

## Interventions

- **DRUG:** 0.9% nitroglycerin in TAM cream
- **DRUG:** vehicle cream

## Key facts

- **NCT ID:** NCT00934427
- **Lead sponsor:** MediQuest Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2010-06
- **Final completion:** 2010-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2010-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934427, "Study of a Topical Formulation for the Treatment and Prevention of Raynaud's Phenomenon Symptoms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00934427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*